Metagenomi, Inc. Common Stock Stock Analysis & AI Score
Metagenomi, Inc. Common Stock (MGX) has an ST Score of 39.0 (C), driven by its Forecast (A) and held back by its Valuation (D). Analysts rate it Buy with a $14.50 price target (+1160.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Metagenomi, Inc. Common Stock (MGX) has an ST Score of 39.0 (C), driven by its Forecast (A) and held back by its Valuation (D). Analysts rate it Buy with a $14.50 price target (+1160.9% upside).
- Strongest
- ForecastA
- Weakest
- ValuationD
All factor grades
- ForecastA
- GrowthC+
- MomentumC
- ProfitabilityC-
- Financial StrengthD+
- ValuationD
- Piotroski2/9
Contact
MGX stock: frequently asked questions
What is MGX's ST Score?
Metagenomi, Inc. Common Stock (MGX) has an ST Score of 39.0 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MGX a buy, hold, or sell?
Analysts rate MGX a Buy, with a price target of $14.50 (+1160.9% vs the current price). Our ST Score grades it C (39.0/100). The ST Score is a data-driven signal, not a recommendation.
What are MGX's factor grades?
Valuation D, Profitability C-, Financial Strength D+, Momentum C, Growth C+, Forecast A.
What is MGX's valuation grade?
Metagenomi, Inc. Common Stock (MGX) earns a valuation grade of D, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MGX's growth grade?
Metagenomi, Inc. Common Stock (MGX) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MGX's profitability grade?
Metagenomi, Inc. Common Stock (MGX) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MGX's financial strength grade?
Metagenomi, Inc. Common Stock (MGX) earns a financial strength grade of D+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for MGX?
The average analyst price target for Metagenomi, Inc. Common Stock (MGX) is $14.50 from 5 analysts, which is +1160.9% versus the recent price of $1.15.
What is MGX's Piotroski score?
Metagenomi, Inc. Common Stock (MGX) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.